Your current location is:{Current column} >>Text
Novavax Surges After Covid Shot Gets EU Regulator’s Nod By
{Current column}4626People have watched
Introduction© Reuters By Dhirendra Tripathi– Novavax stock (NASDAQ:NVAX) climbed 10% in Monday’s premarke ...

By Dhirendra Tripathi
– Novavax stock (NASDAQ:NVAX) climbed 10% in Monday’s premarket trade as the company’s much-delayed Covid vaccine secured the European medicines regulator’s approval for treating adults.
Formal approval from the European Commission is mt5 official website downloadstill outstanding but is generally a rubber-stamp process.
The company will market its NVX-CoV2373 vaccine as Nuvaxovid.
Novavax has a contract to supply the EU with up to 200 million doses of its vaccine. The Serum Institute of India, the Indian company behind a large part of AstraZeneca's (NASDAQ:AZN) Covid-vaccine supplies, will also be making Novavax’s Covid shots. It will later be supplemented with production from other sites in Novavax's global supply chain, the U.S. company said.
Novavax’s Covid vaccine secured the World Health Organization’s nod on Friday. That approval allows it to ship doses to the Covax program, providing another vaccine to low-income countries.
The protein-based vaccine developed by Novavax has been shown in trials to be more than 90% effective against a variety of coronavirus variants. The company plans to begin commercial manufacturing of a vaccine tailored to the highly transmissible Omicron coronavirus variant in January, according to Reuters.
Novavax's shot has received authorization for emergency use in Indonesia and the Philippines, and the company has filed for similar approvals in U.K., U.A.E., Australia, New Zealand, India, Canada, Singapore and Japan. The WHO and the EU approvals should make those clearances easier.
Novavax expects to file with the U.S. Food and Drug Administration for approval in the U.S. by the end of this month.
The company has been late in bringing its Covid vaccine to market, held back by manufacturing challenges, which have since been addressed.
Statement: The content of this article does not represent the views of FTI website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!
Tags:
Related articles
13F Insights: Buffett, Burry Buy Up Financials; Ackman Targets Discretionaries
{Current column}, and slowing . Source: InvestingPro, Top Ideas Screen: ), 850,000 shares in New York Community Banc ...
Read moreAsia FX weakens, dollar strong as mixed China PMI offsets rate cheer By
{Current column}-- Most Asian currencies weakened on Friday, while the dollar retained overnight gains as signs of c ...
Read moreS&P, Nasdaq futures rise ahead of inflation data; Applied Materials surges By Reuters
{Current column}By Amruta Khandekar and Ankika Biswas(Reuters) -Futures tracking the and the Nasdaq gained on Frida ...
Read more
Popular Articles
- Tear gas taints the air as TotalEnergies AGM rejects climate activist resolution By Reuters
- Amazon stock: Bezos selling shares is just 'a distraction'
- US awards $1.5 billion to GlobalFoundries for domestic semiconductor production By Reuters
- Norway to facilitate transfer of funds to Palestinian Authority By Reuters
- Dollar dips against euro as jobs gains offset by negative revisions By Reuters
- AT&T says US cellular outage eases after widespread disruption By Reuters
Latest articles
-
Chinese warship starts live
-
Asian stocks retreat, Nikkei falters as sticky inflation fuels BOJ jitters By
-
China's BYD plans to launch 'high
-
Alcoa, Moderna, Intuitive Machines fall premarket; Berkshire Hathaway rises By
-
Wood: Software stocks next to benefit from AI boom after Nvidia By
-
Bitcoin eyes $60,000, 'FOMO' stirs biggest monthly rally since late 2020 By Reuters